EPIUnit, Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.
Serviço de Pediatria, Unidade de Endocrinologia Pediátrica, Centro Hospitalar Universitário de S. João, Porto, Portugal.
Eur J Pediatr. 2022 Jun;181(6):2423-2432. doi: 10.1007/s00431-022-04442-7. Epub 2022 Mar 16.
We aimed to explore the effect of dehydroepiandrosterone sulphate (DHEAS) at age 7 on areal bone mineral density (aBMD) at age 10 and to distinguish the direct and indirect effects (explained by sexual maturity and by aBMD at age 7), for each sex, after adjustment for body mass index (BMI) z-score. In a subsample of 274 children (139 girls, 135 boys) from Generation XXI cohort, aBMD was assessed with dual-energy X-ray absorptiometry (DXA) scan at ages 7 and 10. The increase in aBMD at age 10 for each 10 µg/dL increase in DHEAS levels at age 7 was estimated using path analysis. Both the direct and the indirect effects were calculated. In girls, higher DHEAS levels at age 7 were associated with higher aBMD at age 10. No direct effect was observed. The indirect effect via higher aBMD at age 7 explained 61% of the total effect, and the indirect effect via higher Tanner stage explained 21%. After adjustment for BMI, the total effect remained statistically significant, explained in 33% by the indirect effect of DHEAS on Tanner stage and Tanner stage on aBMD. In boys, no effect of DHEAS on aBMD was observed.
An indirect effect of DHEAS at age 7 on aBMD at age 10 was found in girls, but not in boys, as higher DHEAS levels were associated with more advanced sexual maturation at age 10, and more advanced sexual maturation to higher aBMD. No direct effect of DHEAS on aBMD was observed.
• Conditions associated with elevated DHEAS, adrenarche's biomarker, are accompanied by advanced bone maturity. • Whether adrenal androgens influence bone mineralization in childhood remains puzzling, and longitudinal data is scarce.
• In girls, but not in boys, higher DHEAS at age 7 was associated with higher aBMD at age 10. • This was partially explained by the indirect effect of DHEAS at age 7 on sexual maturity at age 10, as DHEAS at age 7 was positively associated with sexual maturity at age 10, which was further associated with aBMD.
探索 7 岁时脱氢表雄酮硫酸盐(DHEAS)水平对 10 岁时骨密度(aBMD)的影响,并区分直接和间接影响(通过性成熟和 7 岁时的 aBMD 来解释),每个性别均要进行体重指数(BMI)z 评分调整。在 21 世纪队列的 274 名儿童(女孩 139 名,男孩 135 名)的亚样本中,使用双能 X 射线吸收法(DXA)在 7 岁和 10 岁时评估 aBMD。使用路径分析估计 7 岁时 DHEAS 水平每增加 10μg/dL,10 岁时 aBMD 的增加量。计算了直接和间接影响。在女孩中,7 岁时较高的 DHEAS 水平与 10 岁时较高的 aBMD 相关。未观察到直接影响。通过 7 岁时较高的 aBMD 产生的间接影响解释了总效应的 61%,通过 7 岁时较高的 Tanner 阶段产生的间接影响解释了 21%。调整 BMI 后,总效应仍具有统计学意义,DHEAS 对 Tanner 阶段和 Tanner 阶段对 aBMD 的间接效应解释了 33%。在男孩中,DHEAS 对 aBMD 没有影响。
在女孩中发现了 7 岁时 DHEAS 对 10 岁时 aBMD 的间接影响,但在男孩中没有发现,因为较高的 DHEAS 水平与 10 岁时更成熟的性成熟有关,而更成熟的性成熟与更高的 aBMD 有关。未观察到 DHEAS 对 aBMD 的直接影响。
• 与升高的 DHEAS(肾上腺雄激素的生物标志物)相关的疾病与骨成熟度的提高有关。• 肾上腺雄激素是否会影响儿童的骨矿化仍存在争议,且纵向数据稀缺。
• 在女孩中,但在男孩中,7 岁时较高的 DHEAS 与 10 岁时较高的 aBMD 相关。• 这部分是由于 7 岁时 DHEAS 对 10 岁时性成熟的间接影响所致,因为 7 岁时的 DHEAS 与 10 岁时的性成熟呈正相关,而性成熟与 aBMD 进一步相关。